1. Home
  2. BKSY vs TSHA Comparison

BKSY vs TSHA Comparison

Compare BKSY & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$21.01

Market Cap

658.3M

Sector

Technology

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.88

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
TSHA
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
658.3M
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BKSY
TSHA
Price
$21.01
$5.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$29.00
$10.22
AVG Volume (30 Days)
1.3M
3.7M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$101,731,000.00
$6,310,000.00
Revenue This Year
$8.51
N/A
Revenue Next Year
$31.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$1.05
52 Week High
$33.20
$5.96

Technical Indicators

Market Signals
Indicator
BKSY
TSHA
Relative Strength Index (RSI) 59.27 63.88
Support Level $16.34 $5.37
Resistance Level $23.74 $5.96
Average True Range (ATR) 1.73 0.30
MACD 0.48 0.02
Stochastic Oscillator 63.11 88.79

Price Performance

Historical Comparison
BKSY
TSHA

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: